Paradigm Biopharmaceuticals (ASX:PAR) - Webinar Presentation

13/10/2023 16:42:00

This video is not supported on your device. Click here for the original version.

Paul Rennie - Founder and Managing Director - Paradigm Biopharmaceuticals Limited (ASX:PAR) is a global biopharmaceutical company. Its current focus is a drug for the treatment of osteoarthritis.